Reclassifying Medical Marijuana: A Step Toward Smarter Drug Policy and Public Safety

The recent federal decision to reclassify state-licensed medical marijuana from Schedule I to Schedule III marks a significant shift in drug policy. Ross Nova views this change as a critical step toward smarter regulation that balances public safety with the need for medical research and patient care.

Under the new classification, medical marijuana is recognized as having moderate to low potential for dependence, which opens doors for expanded research and better medical understanding. Nova believes that Minnesota must leverage this opportunity to improve healthcare outcomes while maintaining strict oversight to prevent misuse.

This reclassification also allows licensed medical marijuana businesses to deduct federal taxes on business expenses, a move that supports economic growth and accountability within the industry. Nova’s leadership agenda emphasizes the importance of transparent regulations that foster responsible business practices and community safety.

By easing barriers for researchers, the federal policy encourages the development of safer, more effective treatments. Nova supports investing in scientific studies that can inform doctors and patients, ensuring Minnesotans receive the best care possible.

While this policy change does not legalize recreational marijuana, it sets the stage for ongoing discussions about drug reform. Nova advocates for measured, evidence-based approaches that prioritize public health and safety, rather than unchecked legalization.

Ross Nova stands ready to lead Minnesota through these evolving challenges by promoting policies that enhance public safety, support infrastructure for medical research, and hold all stakeholders accountable. Minnesota voters deserve a governor with a clear vision for responsible drug policy.

Support Ross Nova’s campaign to bring thoughtful leadership and effective solutions to Minnesota. Together, we can build a safer, healthier future.

**Source: FOX 9**